Abstract:In the context of ulcerative coloproctitis (UC), a chronic and non-specific inflammatory condition of the colon and rectum with an elusive etiology, the therapeutic potential of G protein-coupled receptor 109a (GPR109a) has gained prominence. GPR109a is expressed in various cell types including colonic epithelium, adipocytes, neutrophils, and macrophages, positioning it as a promising candidate for pharmacological intervention in colitis.the mechanistic role of GPR109a in a mouse model of UC and to assess its capacity to mitigate the disease's progression.The research team performed an animal study.Conducted by a research team in the biomedical setting of the People's Hospital of Dongxihu District in Wuhan, Hubei province of China.This animal study engaged 16 specific pathogen-free (SPF) male BALB/c mice, aged between 4 to 6 weeks and weighing 20-24 grams each.(1) analysis of rectal lesions via hematoxylin-eosin (HE) staining, (2) the use of transmission electron microscopy to examine suborganelle spatial relationships, (3) Western blot analysis to evaluate a spectrum of protein expressions such as phosphorylated IP3R, p-PERK, p-IRE-1α, mitofusins, NADPH oxidases, TNF-α, and IL-1β, and (4) determination of intracellular calcium concentrations to gauge intestinal barrier function impairment involving specific calcium pathway signals.Results from the study painted a picture of significant infiltration by inflammatory cells within the mucosal and submucosal layers, compounded by pronounced endoplasmic reticulum expansion. Abundant interfaces between the ER and the mitochondria formed multiple structures known as mitochondria-associated membranes or MAMs. When evaluated under calcium-rich conditions, the protein levels mentioned earlier were notably elevated in the GPR109a knockdown (KD) group versus the infection control (NC) counterparts. However, this differential expression disappeared under calcium-depleted conditions or when treated with 2-aminoethyl diphenyl borinate (2-APB). Additionally, fluorescence intensity assays showed marked suppression in the GPR109a-KD plus lipopolysaccharide (LPS) group compared to the control.Drawing these observations to a close, the study concluded that GPR109a has an inhibitory effect on the advancement of ulcerative coloproctitis in mice. This is mediated through the activation of a calcium-induced oxidative stress cascade within macrophages, delineating a promising therapeutic pathway for the management of this inflammatory disease.

Epigenetic Characterization of Ras Association Domain-Containing Protein 10 As A Functional Tumor Suppressor in Gastric Cancer

TL1A Modulates the Severity of Colitis by Promoting Th9 Differentiation and IL-9 Secretion.

Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-κB/MAPKs Pathway

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

The Cxcr2+ subset of the S100a8+ gastric granylocytic myeloid-derived suppressor cell population (G-MDSC) regulates gastric pathology

RGS10 Deficiency Alleviated Intestinal Mucosal Inflammation Through Suppression of Th1/Th17 Cell Immune Responses in Ulcerative Colitis

IL-10 Engages Macrophages to Shift Th17 Cytokine Dependency and Pathogenicity During T Cell-Mediated Colitis (MUC8P.729)

Dysregulated Lysine Acetyltransferase 2b Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10

TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155

Identification of CXCL10 and CXCL11 as the candidate genes involving the development of colitis-associated colorectal cancer

INNATE TL1A SIGNALING PROMOTES INTESTINAL NEUTROPHIL ACTIVATION AND COLITIS ASSOCIATED CANCER

Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis.

Enhanced Susceptibility to Chemically Induced Colitis Caused by Excessive Endosomal TLR Signaling in LRBA-deficient Mice

Myd88 Signaling In Nonhematopoietic Cells Protects Mice Against Induced Colitis By Regulating Specific Egf Receptor Ligands

Inhibition of Ca2+ Induced Macrophage Oxidative Stress Cascade in Mice with Ulcerative Colitis.

Deficiency in epithelium RAD50 aggravates UC via IL-6-mediated JAK1/2-STAT3 signaling and promotes development of colitis-associated cancer in mice

Restoring Treg/Th17 Cell Balance in Ulcerative Colitis Through HRas Silencing and MAPK Pathway Inhibition.

The Protective Role of TLR4 in Intestinal Epithelial Cells through the Regulation of the Gut Microbiota in DSS-Induced Colitis in Mice

MyD88 in Myofibroblasts Enhances Colitis-Associated Tumorigenesis Via Promoting Macrophage M2 Polarization

The Tumor Suppressor Gene, RASSF1A, is Essential for Protection Against Inflammation -Induced Injury

HMGB1 Modulates Macrophage Metabolism and Polarization in Ulcerative Colitis by Inhibiting Cpt1a Expression